fda and semaglutide Oral Gets Approval for CV Event Reduction in High-risk Diabetes Patients The FDA approved a pill

Svetlana Mojsov honored with 2025 Breakthrough Prize Research Associate Professor Svetlana Mojsov is a recipient of this years Breakthrough Prize in Life Sciences for her discovery of the peptide hormone GLP-1 and its role in inducing pancreatic insulin secretion in response to a meal, research that led to a new class of safe and highly effective drugs for type 2 diabetes as well as the treatment of obesity and its co-morbidities

Why GLP-1 Complex

Research and Evidence AHK-Cu has a smaller research base than GHK-Cu, which has been studied since 1973

Optimizing Your Epithalon Research Protocol Quality Control and Sourcing The foundation of any successful epithalon dosage protocol begins with high-quality peptide sourcing

As co-agonists are developed and proposed to have greater glycemic and intestinotrophic effects, further understanding of the endogenous signaling and target cells can only improve tailoring and outcomes

Then divide your desired dose in milligrams by that concentration to determine injection volume in milliliters